Low GAS5 expression may predict poor survival and cisplatin resistance in cervical cancer

Cisplatin resistance is a major challenge in cervical cancer (CC) chemotherapy. Growth arrest‐specific 5 (GAS5) has been reported to be a tumour suppressor gene in CC. However, the mechanism of GAS5 in chemoresistance remains undetermined. Our research evaluated GAS5 expression in normal and CC tiss...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Xingyu, Zhong, Guanglei, Wang, Yuhan, Lin, Zhongqiu, Lin, Rongchun, Yao, Tingting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359315/
https://www.ncbi.nlm.nih.gov/pubmed/32661236
http://dx.doi.org/10.1038/s41419-020-2735-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359315/
https://www.ncbi.nlm.nih.gov/pubmed/32661236
http://dx.doi.org/10.1038/s41419-020-2735-2

Ejemplares similares